Evidence map›Paper›PMID 40804450›Full record

ReviewCellular & molecular immunology2025

Beyond the gut: decoding the gut-immune-brain axis in health and disease.

John Chulhoon Park, Leechung Chang, Ho-Keun Kwon, Sin-Hyeog Im

Abstract readReview
In one paragraph

Review in Cellular & molecular immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

John Chulhoon Park *Department of Life Sciences, POSTECH Biotech Center, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.ORCID 0000-0001-5705-2862
Leechung Chang *Department of Microbiology and Immunology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Ho-Keun KwonDepartment of Life Sciences, POSTECH Biotech Center, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea. HK@yuhs.ac.
Sin-Hyeog ImDepartment of Life Sciences, POSTECH Biotech Center, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea. iimsh@postech.ac.kr.ORCID 0000-0002-3173-1856

Funding

National Research Foundation of Korea (NRF) RS-2019-NR040072National Research Foundation of Korea (NRF) RS-2024-00345575National Research Foundation of Korea (NRF) RS-2024-00361620National Research Foundation of Korea (NRF) RS-2024-00438443National Research Foundation of Korea (NRF) RS-2025-00561456
6 · The paper itself

Abstract

Emerging research underscores the pivotal role of the gut-immune-brain axis, a dynamic bidirectional communication system involving intricate interactions between the gut microbiota, immune responses, and the central nervous system. Gut microbes and their metabolites have profound effects on immune and neurological homeostasis, influencing the development and function of multiple physiological systems. Disruption of the composition of the gut microbiota and barrier integrity has been implicated in various neurological and psychiatric disorders, including autism spectrum disorder, Alzheimer's disease, Parkinson's disease, depression, and anxiety. Most insights into these host-microbiota interactions come from preclinical models, revealing both the complexity and potential therapeutic opportunities of the gut-brain communication pathways. This review synthesizes the current understanding of these intricate interactions, exploring how microbiota-driven modulation of the gut and brain barriers, immune signaling, and neuronal pathways, such as those through the vagus nerve, contributes to health and disease. We further explore therapeutic implications, including personalized precision microbiota interventions, microbiome-derived biomarkers, and barrier-strengthening strategies. Advancing this field offers transformative potential for developing innovative, personalized therapies tailored to individual microbiomes and immune profiles, ultimately redefining clinical approaches to neurological and immune-mediated diseases.

Indexed as

BrainBrain-Gut AxisGastrointestinal MicrobiomeAnimalsHumansImmune SystemBarrier integrityGut–immune–brain axisGut microbiotaNeuroimmunologyNeurological disorders

Identifiers

PMID40804450
PMCPMC12575876

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.